Global Contraceptive Drug Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Contraceptive Drug Market Insights, Forecast to 2034
Contraceptives (birth control pills) are medications that prevent pregnancy. They are one method of birth control.
Global Contraceptive Drug market is expected to reach to US$ 14260 million in 2024, with a positive growth of %, compared with US$ 13450 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Contraceptive Drug industry is evaluated to reach US$ 20340 million in 2029. The CAGR will be 6.1% during 2024 to 2029.
The contraceptive drug market is projected to experience significant growth in the foreseeable future. Factors such as increasing awareness about family planning, rising demand for effective birth control methods, and advancements in contraceptive drug formulations drive market growth. The market is highly competitive, with several pharmaceutical companies offering a wide range of contraceptive drugs. However, challenges such as potential side effects, adherence issues, and cultural barriers may hinder market expansion. Nonetheless, the contraceptive drug market holds promising opportunities, driven by the need for safe and convenient contraceptive options, and the growing focus on reproductive health and family planning worldwide.
Report Covers
This report presents an overview of global Contraceptive Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Contraceptive Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Cipla
Bayer
Merck
Teva Pharmaceutical
AbbVie
Pfizer
Reckitt Benckiser
Mankind Pharma
Janssen Pharmaceutical
HLL Lifecare
Mithra Pharmaceuticals
Segment by Type
Oral Contraceptives
Contraceptive Injectable
Topical Contraceptive Patch
Hospital Pharmacy
Independent Pharmacy
Online Platform
Clinics
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Contraceptive Drug plant distribution, commercial date of Contraceptive Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Contraceptive Drug introduction, etc. Contraceptive Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Contraceptive Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Global Contraceptive Drug market is expected to reach to US$ 14260 million in 2024, with a positive growth of %, compared with US$ 13450 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Contraceptive Drug industry is evaluated to reach US$ 20340 million in 2029. The CAGR will be 6.1% during 2024 to 2029.
The contraceptive drug market is projected to experience significant growth in the foreseeable future. Factors such as increasing awareness about family planning, rising demand for effective birth control methods, and advancements in contraceptive drug formulations drive market growth. The market is highly competitive, with several pharmaceutical companies offering a wide range of contraceptive drugs. However, challenges such as potential side effects, adherence issues, and cultural barriers may hinder market expansion. Nonetheless, the contraceptive drug market holds promising opportunities, driven by the need for safe and convenient contraceptive options, and the growing focus on reproductive health and family planning worldwide.
Report Covers
This report presents an overview of global Contraceptive Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Contraceptive Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Cipla
Bayer
Merck
Teva Pharmaceutical
AbbVie
Pfizer
Reckitt Benckiser
Mankind Pharma
Janssen Pharmaceutical
HLL Lifecare
Mithra Pharmaceuticals
Segment by Type
Oral Contraceptives
Contraceptive Injectable
Topical Contraceptive Patch
Segment by Application
Hospital Pharmacy
Independent Pharmacy
Online Platform
Clinics
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Contraceptive Drug plant distribution, commercial date of Contraceptive Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Contraceptive Drug introduction, etc. Contraceptive Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Contraceptive Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports